Literature DB >> 1193498

Serum lysozyme in mice subjected to combined immunosuppression with 6-mercaptopurine and hydrocortisone.

J Prixová.   

Abstract

Simultaneous peroral administration of 6-mercaptopurine (80 mg/kg per day) and subcutaneous injection of hydrocortisone (1 mg/mouse per day) for ten days results in increased lethality and more pronounced decrease in total peripheral leukocyte count and serum lysozyme levels as compared with mice receiving each drug separately. The possible mechanism of this effect is discussed.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1193498     DOI: 10.1007/bf02891711

Source DB:  PubMed          Journal:  Folia Microbiol (Praha)        ISSN: 0015-5632            Impact factor:   2.099


  7 in total

1.  [Effect of 6-mercaptopurine on various factors of natural resistance to infection. 1. Mortality, weight, leukocytes and reticulocytes in peripheral blood].

Authors:  J Prixová
Journal:  Sb Ved Pr Lek Fak Karlovy Univerzity Hradci Kralove Suppl       Date:  1975

2.  The effect of immunosuppressive therapy on serum factors involved in resistance to infection in the rat.

Authors:  R J Sharbaugh; J B Grogan
Journal:  J Reticuloendothel Soc       Date:  1970-06

3.  The anti-inflammatory effect of some immunosuppressive agents.

Authors:  J E Stevens; D A Willoughby
Journal:  J Pathol       Date:  1969-02       Impact factor: 7.996

4.  Serum muramidase and granulocyte turnover.

Authors:  M E Fink; S C Finch
Journal:  Proc Soc Exp Biol Med       Date:  1968-02

5.  Suppression of reticuloendothelial function in the rat with cyclophosphamide.

Authors:  R J Sharbaugh; J B Grogan
Journal:  J Bacteriol       Date:  1969-10       Impact factor: 3.490

6.  Studies on lysosomes. I. The effects of endotoxin, endotoxin tolerance, and cortisone on the release of acid hydrolases from a granular fraction of rabbit liver.

Authors:  G WEISSMANN; L THOMAS
Journal:  J Exp Med       Date:  1962-10-01       Impact factor: 14.307

7.  Serum and urinary lysozyme (muramidase) in monocytic and monomyelocytic leukemia.

Authors:  E F Osserman; D P Lawlor
Journal:  J Exp Med       Date:  1966-11-01       Impact factor: 14.307

  7 in total
  2 in total

1.  Listeria monocytogenes is resistant to lysozyme through the regulation, not the acquisition, of cell wall-modifying enzymes.

Authors:  Thomas P Burke; Anastasia Loukitcheva; Jason Zemansky; Richard Wheeler; Ivo G Boneca; Daniel A Portnoy
Journal:  J Bacteriol       Date:  2014-08-25       Impact factor: 3.490

2.  Mutations of the Listeria monocytogenes peptidoglycan N-deacetylase and O-acetylase result in enhanced lysozyme sensitivity, bacteriolysis, and hyperinduction of innate immune pathways.

Authors:  Chris S Rae; Aimee Geissler; Paul C Adamson; Daniel A Portnoy
Journal:  Infect Immun       Date:  2011-07-18       Impact factor: 3.441

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.